Our Pharmaceuticals business has a broad portfolio of innovative and established medicines in respiratory, HIV, immuno-inflammation, and oncology. We are strengthening our R&D pipeline by focusing on immunology, human genetics, and advanced technologies to help us deliver transformational new medicines for patients. The business generated sales of \xc2\xa317 billion in 2020.
Our strategy is to research and produce innovative, high-quality, and needed medicines, making these as accessible as possible to countries at all levels of income and development. We focus on creating a differentiated pipeline, leading in HIV and respiratory, and developing our presence in specialty therapy areas, including oncology and immuno-inflammation.
Our portfolio includes innovative and established medicines, and we have leading global positions in respiratory disease and HIV. We have been a leader in respiratory disease for over 40 years and have a portfolio of mature products.
We are creating an agile and more competitive Pharma business equipped to win in a dynamic external environment by improving our pipeline and performance. We will prioritize taking rapid, decisive action to focus the portfolio and accelerate timelines across four core areas to maintain or build global leadership (Respiratory, HIV/Infectious Disease, Oncology, and Immuno-Inflammation). Our integrated Pharma business will become a more competitive organisation: R&D, Manufacturing, and Commercial will combine to simplify decision-making and increase efficiency. Plus, we will continue to be a \xe2\x80\x98force for good\xe2\x80\x99 driven equally by competitive performance and our values.
Find additional details about our Pharma business and portfolio:
**The ideal candidate will be based in St. John\'s, Newfoundland and Labrador**
Details (your) Responsibilities
MNCJobz.com will not be responsible for any payment made to a third-party. All Terms of Use are applicable.